- Home
- PRKS vs MANE Comparison
PRKS vs MANE Comparison
Compare PRKS & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRKS | MANE |
|---|---|---|
| Founded | 1959 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRKS | MANE |
|---|---|---|
| Price | $40.29 | $100.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $47.50 | ★ $83.33 |
| AVG Volume (30 Days) | ★ 1.0M | 533.6K |
| Earning Date | 05-11-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,263,324,000.00 | N/A |
| Revenue This Year | $3.45 | N/A |
| Revenue Next Year | $3.08 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $28.77 | $36.26 |
| 52 Week High | $56.95 | $117.71 |
Technical Indicators
Market Signals| Indicator | PRKS | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 65.01 | 54.47 |
| Support Level | $33.89 | $95.70 |
| Resistance Level | $41.42 | $117.71 |
| Average True Range (ATR) | 2.11 | 7.01 |
| MACD | 0.42 | -1.90 |
| Stochastic Oscillator | 86.02 | 34.46 |
Price Performance
Historical ComparisonAbout PRKS United Parks & Resorts Inc.
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.